583 related articles for article (PubMed ID: 18053605)
1. Acute non-cytopathic bovine viral diarrhea virus infection induces pronounced type I interferon response in pregnant cows and fetuses.
Smirnova NP; Bielefeldt-Ohmann H; Van Campen H; Austin KJ; Han H; Montgomery DL; Shoemaker ML; van Olphen AL; Hansen TR
Virus Res; 2008 Mar; 132(1-2):49-58. PubMed ID: 18053605
[TBL] [Abstract][Full Text] [Related]
2. Induction of interferon-gamma and downstream pathways during establishment of fetal persistent infection with bovine viral diarrhea virus.
Smirnova NP; Webb BT; McGill JL; Schaut RG; Bielefeldt-Ohmann H; Van Campen H; Sacco RE; Hansen TR
Virus Res; 2014 Apr; 183():95-106. PubMed ID: 24530541
[TBL] [Abstract][Full Text] [Related]
3. Development of fetal and placental innate immune responses during establishment of persistent infection with bovine viral diarrhea virus.
Smirnova NP; Webb BT; Bielefeldt-Ohmann H; Van Campen H; Antoniazzi AQ; Morarie SE; Hansen TR
Virus Res; 2012 Aug; 167(2):329-36. PubMed ID: 22659490
[TBL] [Abstract][Full Text] [Related]
4. Maternal and fetal response to fetal persistent infection with bovine viral diarrhea virus.
Hansen TR; Smirnova NP; Van Campen H; Shoemaker ML; Ptitsyn AA; Bielefeldt-Ohmann H
Am J Reprod Immunol; 2010 Oct; 64(4):295-306. PubMed ID: 20678166
[TBL] [Abstract][Full Text] [Related]
5. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
6. [Bovine diarrhea virus: an update].
Kobrak A; Weber EL
Rev Argent Microbiol; 1997; 29(1):47-61. PubMed ID: 9229725
[TBL] [Abstract][Full Text] [Related]
7. Transplacental infection with non-cytopathic bovine viral diarrhoea virus types 1b and 2: viral spread and molecular neuropathology.
Bielefeldt-Ohmann H; Tolnay AE; Reisenhauer CE; Hansen TR; Smirnova N; Van Campen H
J Comp Pathol; 2008; 138(2-3):72-85. PubMed ID: 18295788
[TBL] [Abstract][Full Text] [Related]
8. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
[TBL] [Abstract][Full Text] [Related]
10. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
[TBL] [Abstract][Full Text] [Related]
11. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
[TBL] [Abstract][Full Text] [Related]
12. Bovine maternal, fetal and neonatal responses to bovine viral diarrhea virus infections.
Kelling CL; Topliff CL
Biologicals; 2013 Jan; 41(1):20-5. PubMed ID: 23084809
[TBL] [Abstract][Full Text] [Related]
13. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC
J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841
[TBL] [Abstract][Full Text] [Related]
15. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
[TBL] [Abstract][Full Text] [Related]
16. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
Xue W; Mattick D; Smith L
Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
[TBL] [Abstract][Full Text] [Related]
17. Activation of cell signaling pathways is dependant on the biotype of bovine viral diarrhea viruses type 2.
Bendfeldt S; Ridpath JF; Neill JD
Virus Res; 2007 Jun; 126(1-2):96-105. PubMed ID: 17376555
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
[TBL] [Abstract][Full Text] [Related]
19. Investigation of a dual fetal infection model with bovine viral diarrhoea viruses (BVDV)-1 and BVDV-2.
Makoschey B; Janssen MG
Arch Virol; 2011 Oct; 156(10):1831-3. PubMed ID: 21597952
[TBL] [Abstract][Full Text] [Related]
20. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
